| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5565628 | Journal of Obstetric, Gynecologic & Neonatal Nursing | 2017 | 6 Pages |
Abstract
New therapeutics, such as ivacaftor, and the combination drug lumacaftor/ivacaftor that target the underlying genetic cause of cystic fibrosis are being hailed as game-changers in this era of personalized medicine. Although these drugs improve lung function, their effects on female fertility have not been studied. In this case report we describe one woman's experience with ivacaftor and her unanticipated pregnancy. Implications related to comprehensive sexual and reproductive health care for women with cystic fibrosis are presented.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Sigrid Ladores, Traci M. Kazmerski, Steven M. Rowe,